CASSANDRA MARKHAM: Open Payments
NPI 1417659228 · EAST MEADOW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 86 payments from 15 companies in 2025. Trend: 2023 $85 · 2024 $1,551 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $587 |
| SK Life Science, Inc. | 16 | $206 |
| Neurelis, Inc. | 10 | $161 |
| Neurocrine BioSciences, Inc. | 4 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| Eisai Inc. | 4 | $78 |
| PFIZER INC. | 4 | $76 |
| Grifols USA, LLC | 1 | $39 |
| Alexion Pharmaceuticals, Inc. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
Products named: QULIPTA, UBRELVY, VALTOCO, BOTOX, INGREZZA, KESIMPTA, Leqembi, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across NY — which companies pay providers there.
